Metabolic signatures reveal how exercise intensity shields the heart in diabetes

People with type 2 diabetes who move more tend to suffer fewer major cardiovascular events, and a new analysis of UK Biobank data suggests that the metabolic machinery behind that protection operates at every exercise intensity, from brisk walking to vigorous workouts. Using nuclear magnetic resonance metabolomics, researchers traced how intensity-specific metabolic signatures statistically account for part of the link between physical activity and reduced cardiovascular risk.

The study included 6,887 participants with type 2 diabetes who had complete physical activity records and plasma NMR metabolomics data. Over a median follow-up of 15.17 years, 974 major adverse cardiovascular events, or MACE, occurred. Total physical activity showed an inverse, dose–response association with MACE risk (P overall = 0.007), with the benefit plateauing at roughly 3,500–4,000 MET-minutes per week.

Compared with the least active group, moderately active participants had a 17% lower risk of MACE (HR = 0.829, 95% CI: 0.711–0.966), while the most active group showed a 27% reduction (HR = 0.734, 95% CI: 0.620–0.870). These are observational associations from a prospective cohort, not proof of causation, but the dose–response pattern is consistent with a protective relationship.

To probe the mechanisms, the team built three metabolic signature scores—one each for walking, moderate-, and vigorous-intensity activity—using elastic net regression across 41 candidate metabolites measured by NMR spectroscopy. All three scores were independently associated with reduced MACE risk (all p < 0.001), and the three were highly correlated with one another (r = 0.78–0.84), pointing to substantially overlapping metabolic pathways rather than fully distinct intensity-specific biology.

GlycA, a composite marker of systemic inflammation, and albumin, a marker of hepatic synthetic capacity, appeared in all three intensity-specific scores and showed the strongest nominal mediation signals among the 41 metabolites tested. Glucose, also selected into all three scores, showed a smaller but nominally significant signal. Together, the authors interpret this pattern as a shared contribution from systemic inflammation, liver function, and glycemic control across all exercise intensities.

In joint mediation modeling, the three metabolic scores together statistically accounted for 26.1% of the exercise–MACE association (95% CI: 15.1%–48.8%), with the vigorous-intensity pathway contributing the largest share at 22.7%. Because the scores were so strongly correlated, the researchers also modeled each one separately: all three, including walking (proportion mediated = 18.9%), showed significant metabolic mediation (all p < 0.001). The vigorous-intensity pathway is plausibly driven by lipid remodeling, according to the study’s conclusions, though mediation analysis quantifies statistical contribution rather than establishing causal mechanism.

One notable finding concerns walking. Despite being the lowest intensity, walking retained the strongest independent direct association with reduced MACE risk, alongside a metabolic mediation effect comparable in size to moderate- and vigorous-intensity exercise. That suggests the least demanding form of activity engages much of the same metabolic machinery as harder workouts, a potentially encouraging message for people who cannot undertake vigorous exercise.

The authors caution that these findings provide only preliminary support for intensity-stratified exercise guidance in type 2 diabetes. Objective measurement of exercise intensity and prospective validation are needed before the results could inform formal exercise prescriptions. The mediation estimates also carry wide confidence intervals, and residual confounding cannot be excluded in an observational cohort.

Even with those limitations, the study offers a metabolomics-informed map of how physical activity may confer cardioprotection in diabetes, linking inflammation, glycemic control, and lipid remodeling to a measurable reduction in cardiovascular events. It reframes exercise not as a single behavior with one mechanism, but as a spectrum of intensities that converge on overlapping metabolic pathways, each contributing a quantifiable share of the observed cardiovascular benefit.

Subject of Research: Intensity-specific metabolic signatures linking physical activity to cardiovascular risk reduction in type 2 diabetes

Article Title: Exercise intensity-dependent metabolic signatures and cardiovascular protection in type 2 diabetes: evidence from NMR metabolomics in the UK Biobank

Article References: Yang, Y., Li, J., Li, S., An, K., Zhang, X., Zhang, F., An, Z., Li, S., Zhang, Y., Tong, N., Li, S., & Lyu, Q. (2026). Exercise intensity-dependent metabolic signatures and cardiovascular protection in type 2 diabetes: evidence from NMR metabolomics in the UK Biobank. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-026-03426-3

Image Credits: AI Generated

DOI: 10.1186/s12933-026-03426-3

Keywords: type 2 diabetes, UK Biobank, metabolomics, exercise intensity, cardiovascular risk, NMR spectroscopy, mediation analysis, physical activity, MACE, GlycA, lipid remodeling, walking